在BRCA1缺乏模型中,DNA拓酶IIβ抑制阻断了DNA末端切除,并与PARPi协同作用
Rosa Camarillo1, Rosario Prados-Carvajal1, Andrés Cruz-García1
1Facultad de Biología, Universidad de Sevilla, Sevilla 41080, Spain; Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Sevilla 41092, Spain.
DNA repair
|July 2, 2025
概括
默巴龙是一种DNA拓酶II抑制剂,通过影响DNA末端切除,影响DNA修复. 缺乏BRCA1的癌细胞对默巴龙具有敏感性,为特定癌症类型提供潜在的治疗策略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 是一个遗传学.
背景情况:
- DNA末端切除对于染色体修复至关重要,并且受到严格监管.
- 对DNA末端切除的失调会影响细胞存活,特别是在细胞毒性化疗下.
- 小分子为调节DNA修复途径提供了潜力.
研究的目的:
- 为了识别影响DNA末端切除的小分子.
- 为了阐明一种DNA拓酶II抑制剂merbarone的作用机制.
- 研究拓聚酶IIβ在DNA断裂处理中的作用及其对癌症治疗的影响.
主要方法:
- 识别影响DNA末端切除的小分子.
- 默巴龙的作用模式研究,包括与G4四重体的相互作用.
- 细胞模型用于评估BRCA1缺陷和突变细胞对默巴龙和PARP抑制剂的敏感性.
- 使用患者衍生异种移植 (PDX) 模型的体内研究.
主要成果:
- 默巴龙会影响DNA末端切除,并突出显示托酶IIβ.β的作用.
- 默巴龙的疗效受G4四重复形成的影响.
- 缺乏BRCA1的癌细胞对默巴龙具有敏感性.
- 具有对PARP抑制剂 (PARPi) 耐药性的BRCA1外因子11突变细胞对美巴龙和PARPi联合治疗敏感.
- 组合疗法在具有BRCA1外因子11突变的抗PARPi抗性PDX模型中显示出轻微的抗瘤作用.
结论:
- 默巴龙代表了一种针对癌症的DNA修复的新型治疗剂.
- 向拓酶IIβ和利用G4四重复相互作用可能是有益的.
- 与美巴龙和PARPi的联合治疗显示出在BRCA1突变癌症中克服PARPi耐药性的潜力.
相关概念视频
02:37Restarting Stalled Replication Forks
5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
02:02DNA Topoisomerases
32.2K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
32.2K
02:37DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
02:31Homologous Recombination
52.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.6K
01:23Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
01:02Long-patch Base Excision Repair
7.2K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K